Derek J Smith
University of Cambridge
H-index: 63
Europe-United Kingdom
Top articles of Derek J Smith
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Immune imprinting revealed by SARS-CoV-2 Omicron infection prior to vaccination | Ravindra Gupta Adam Abdullahi James Onyemata Sam Turner Martin Edun | 2024/4/15 | |
Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster | The Journal of Infectious Diseases | Annika Rössler Ludwig Knabl Antonia Netzl David Bante Wegene Borena | 2024/3/15 |
Assessment of the antigenic evolution of a clade 6B. 1 human H1N1pdm influenza virus revealed differences between ferret and human convalescent sera | Ebiomedicine | Shufang Fan Huihui Kong Lavanya Babujee Robert Presler Peter Jester | 2024/3/1 |
Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA. 2.86 | bioRxiv | Sam Turner Gayatri Amirthalingam Dalan Bailey Dan H Barouch Kevin R Bewley | 2024 |
The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity | Emerging microbes & infections | Alba Escalera Manon Laporte Sam Turner Umut Karakus Ana S Gonzalez-Reiche | 2024/12/31 |
Mapping SARS-CoV-2 antigenic relationships and serological responses | Science | Samuel H Wilks Barbara Mühlemann Xiaoying Shen Sina Türeli Eric B LeGresley | 2023/10/6 |
Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants | bioRxiv | Barbara Mühlemann Jakob Trimpert Felix Walper Marie Luisa Schmidt Simon Schroeder | 2023 |
Bivalent and monovalent SARS-CoV-2 variant vaccine boosters improve coverage of the known antigenic landscape: results of the COVID-19 variant immunologic landscape (COVAIL) trial | Research Square | Angela Branche Nadine Rouphael David Diemert Ann Falsey Cecilia Losada | 2023/5/5 |
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera | bioRxiv | Barbara Mühlemann Samuel H Wilks Lauren Baracco Meriem Bekliz Juan Manuel Carreño | 2023/9/27 |
Immunogenicity of the BA. 1 and BA. 4/5 Bivalent Boosts: A Brief Report of Preliminary Results from the COVAIL Randomized Clinical Trial (preprint) | Angela R Branche Nadine Rouphael Cecilia Losada Lindsey R Baden Evan J Anderson | 2023 | |
US National Institutes of Health Prioritization of SARS-CoV-2 Variants | Emerging Infectious Diseases | Sam Turner Arghavan Alisoltani Debbie Bratt Liel Cohen-Lavi Bethany L Dearlove | 2023/5 |
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial | Nature medicine | Angela R Branche Nadine G Rouphael David J Diemert Ann R Falsey Cecilia Losada | 2023/9 |
Antigenic mapping of emerging SARS-CoV-2 omicron variants BM. 1.1. 1, BQ. 1.1, and XBB. 1 | The Lancet Microbe | Anna Z Mykytyn Miruna E Rosu Adinda Kok Melanie Rissmann Geert van Amerongen | 2023/5/1 |
Immunogenicity of the BA. 1 and BA. 4/BA. 5 SARS-CoV-2 bivalent boosts: preliminary results from the COVAIL randomized clinical trial | medRxiv | Angela R Branche Nadine G Rouphael Cecilia Losada Lindsey R Baden Evan J Anderson | 2023/3/31 |
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA. 1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial | The Journal of infectious diseases | Nadine G Rouphael Angela R Branche David J Diemert Ann R Falsey Cecilia Losada | 2023/12/15 |
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography. | Ludwig Knabl Wegene Borena Annika Rössler Antonia Netzl David Bante | 2023/8/26 | |
Characterization of A/H7 influenza virus global antigenic diversity and key determinants in the hemagglutinin globular head mediating A/H7N9 antigenic evolution | Mbio | Adinda Kok Rachel Scheuer Theo M Bestebroer David F Burke Samuel H Wilks | 2023/10/31 |
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera | bioRxiv | Annika Roessler Antonia Netzl Ludwig Knabl Samuel H Wilks Barbara Muehlemann | 2023 |
Immunogenicity of the BA. 1 and BA. 4/BA. 5 severe acute respiratory syndrome coronavirus 2 bivalent boosts: preliminary results from the COVAIL randomized clinical trial | Clinical Infectious Diseases | Angela R Branche Nadine G Rouphael Cecilia Losada Lindsey R Baden Evan J Anderson | 2023/8/15 |
Influenza virus infection history shapes antibody responses to influenza vaccination | Nature medicine | Maria Auladell Hoang Vu Mai Phuong Le Thi Quynh Mai Yeu-Yang Tseng Louise Carolan | 2022/2 |
